Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocket

We report computer-aided design of new lactone–chalcone and isatin–chalcone (HLCIC) inhibitors of the falcipain-2 (PfFP-2). 3D models of 15 FP-2:HLCIC1-15 complexes with known observed activity (IC50exp) were prepared to establish a quantitative structure–activity (QSAR) model and linear correlation...

Full description

Bibliographic Details
Main Authors: Koffi N’Guessan Placide Gabin Allangba, Mélalie Keita, Raymond Kre N’Guessan, Eugene Megnassan, Vladimir Frecer, Stanislav Miertus
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Online Access:http://dx.doi.org/10.1080/14756366.2018.1564288
id doaj-81ff42822d174810b7d71172ba3115fa
record_format Article
spelling doaj-81ff42822d174810b7d71172ba3115fa2020-11-25T01:16:35ZengTaylor & Francis GroupJournal of Enzyme Inhibition and Medicinal Chemistry1475-63661475-63742019-01-0134154756110.1080/14756366.2018.15642881564288Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocketKoffi N’Guessan Placide Gabin Allangba0Mélalie Keita1Raymond Kre N’Guessan2Eugene Megnassan3Vladimir Frecer4Stanislav Miertus5University of Abobo Adjamé (now Nangui Abrogoua)University of Abobo Adjamé (now Nangui Abrogoua)University of Abobo Adjamé (now Nangui Abrogoua)University of Abobo Adjamé (now Nangui Abrogoua)ICS-UNIDOICS-UNIDOWe report computer-aided design of new lactone–chalcone and isatin–chalcone (HLCIC) inhibitors of the falcipain-2 (PfFP-2). 3D models of 15 FP-2:HLCIC1-15 complexes with known observed activity (IC50exp) were prepared to establish a quantitative structure–activity (QSAR) model and linear correlation between relative Gibbs free energy of enzyme:inhibitor complex formation (ΔΔGcom) and IC50exp: pIC50exp = −0.0236 × ΔΔGcom+5.082(#); R2 = 0.93. A 3D pharmacophore model (PH4) derived from the QSAR directed our effort to design novel HLCIC analogues. During the design, an initial virtual library of 2621440 HLCIC was focused down to 18288 drug-like compounds and finally, PH4 screened to identify 81 promising compounds. Thirty-three others were added from an intuitive substitution approach intended to fill better the enzyme S2 pocket. One hundred and fourteen theoretical IC50 (IC50pre) values were predicted by means of (#) and their pharmacokinetics (ADME) profiles. More than 30 putative HLCICs display IC50pre 100 times superior to that of the published most active training set inhibitor HLCIC1.http://dx.doi.org/10.1080/14756366.2018.1564288falcipain-2plasmodium falciparummolecular modellingqsar modelpharmacophorevirtual librarypharmacokinetics
collection DOAJ
language English
format Article
sources DOAJ
author Koffi N’Guessan Placide Gabin Allangba
Mélalie Keita
Raymond Kre N’Guessan
Eugene Megnassan
Vladimir Frecer
Stanislav Miertus
spellingShingle Koffi N’Guessan Placide Gabin Allangba
Mélalie Keita
Raymond Kre N’Guessan
Eugene Megnassan
Vladimir Frecer
Stanislav Miertus
Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocket
Journal of Enzyme Inhibition and Medicinal Chemistry
falcipain-2
plasmodium falciparum
molecular modelling
qsar model
pharmacophore
virtual library
pharmacokinetics
author_facet Koffi N’Guessan Placide Gabin Allangba
Mélalie Keita
Raymond Kre N’Guessan
Eugene Megnassan
Vladimir Frecer
Stanislav Miertus
author_sort Koffi N’Guessan Placide Gabin Allangba
title Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocket
title_short Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocket
title_full Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocket
title_fullStr Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocket
title_full_unstemmed Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the S2 active site pocket
title_sort virtual design of novel plasmodium falciparum cysteine protease falcipain-2 hybrid lactone–chalcone and isatin–chalcone inhibitors probing the s2 active site pocket
publisher Taylor & Francis Group
series Journal of Enzyme Inhibition and Medicinal Chemistry
issn 1475-6366
1475-6374
publishDate 2019-01-01
description We report computer-aided design of new lactone–chalcone and isatin–chalcone (HLCIC) inhibitors of the falcipain-2 (PfFP-2). 3D models of 15 FP-2:HLCIC1-15 complexes with known observed activity (IC50exp) were prepared to establish a quantitative structure–activity (QSAR) model and linear correlation between relative Gibbs free energy of enzyme:inhibitor complex formation (ΔΔGcom) and IC50exp: pIC50exp = −0.0236 × ΔΔGcom+5.082(#); R2 = 0.93. A 3D pharmacophore model (PH4) derived from the QSAR directed our effort to design novel HLCIC analogues. During the design, an initial virtual library of 2621440 HLCIC was focused down to 18288 drug-like compounds and finally, PH4 screened to identify 81 promising compounds. Thirty-three others were added from an intuitive substitution approach intended to fill better the enzyme S2 pocket. One hundred and fourteen theoretical IC50 (IC50pre) values were predicted by means of (#) and their pharmacokinetics (ADME) profiles. More than 30 putative HLCICs display IC50pre 100 times superior to that of the published most active training set inhibitor HLCIC1.
topic falcipain-2
plasmodium falciparum
molecular modelling
qsar model
pharmacophore
virtual library
pharmacokinetics
url http://dx.doi.org/10.1080/14756366.2018.1564288
work_keys_str_mv AT koffinguessanplacidegabinallangba virtualdesignofnovelplasmodiumfalciparumcysteineproteasefalcipain2hybridlactonechalconeandisatinchalconeinhibitorsprobingthes2activesitepocket
AT melaliekeita virtualdesignofnovelplasmodiumfalciparumcysteineproteasefalcipain2hybridlactonechalconeandisatinchalconeinhibitorsprobingthes2activesitepocket
AT raymondkrenguessan virtualdesignofnovelplasmodiumfalciparumcysteineproteasefalcipain2hybridlactonechalconeandisatinchalconeinhibitorsprobingthes2activesitepocket
AT eugenemegnassan virtualdesignofnovelplasmodiumfalciparumcysteineproteasefalcipain2hybridlactonechalconeandisatinchalconeinhibitorsprobingthes2activesitepocket
AT vladimirfrecer virtualdesignofnovelplasmodiumfalciparumcysteineproteasefalcipain2hybridlactonechalconeandisatinchalconeinhibitorsprobingthes2activesitepocket
AT stanislavmiertus virtualdesignofnovelplasmodiumfalciparumcysteineproteasefalcipain2hybridlactonechalconeandisatinchalconeinhibitorsprobingthes2activesitepocket
_version_ 1725149225665167360